SAB Biotherapeutics Inc. (SABS)
undefined
undefined%
At close: undefined
4.08
1.24%
After-hours Dec 13, 2024, 04:00 PM EST

Ratios (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19
PE Ratio -0.23 -0.34 -3.06 3.20 -117.14
PS Ratio 4.24 0.27 0.88 1.17 320.52
PB Ratio 0.17 0.21 1.38 1.65 -478.48
P/FCF Ratio -0.38 -0.89 -7.43 -23.63 -112.30
P/OCF Ratio -0.38 1.71 14.20 6.44 -119.72
OCF/S Ratio -2.80 0.04 0.02 0.05 -0.67
Debt / Equity Ratio 0.01 0.02 0.01 0.00 -0.22
Quick Ratio 1.36 0.37 0.49 0.78 0.50
Current Ratio 1.36 0.37 0.49 0.78 0.50
Asset Turnover 0.03 0.47 0.77 0.98 0.19
Interest Coverage -30.19 -23.97 -11.37 10.95 -5.06
Return on Equity (ROE) -73.64% -60.34% -45.25% 51.57% 408.46%
Return on Assets (ROA) -50.27%-36.82%-21.98%35.58%-52.31%
Return on Capital (ROIC) -52.07%-80.52%-24.49%45.20%-64.80%
Dividend Yield 0.00%0.00%0.00%0.00%0.00%
Payout Ratio 0.00% 0.00% 0.00% 0.00% 0.00%
Gross Profit Margin -16.82% 21.56% 24.32% 25.00% 25.00%
Net Profit Margin -471.13% -19.60% -7.16% 9.11% -68.40%